-
Uncategorized2 weeks agoSTAT+: Rare disease drugmakers try to avoid Trump price cuts
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...
-
Uncategorized2 weeks ago
Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesity
With PolyPeptide manufacturing peptides such as GLP-1 medicines, Samsung Biologics has identified the deal as a way to tap into fast-growing demand for obesity drug production...
-
Uncategorized2 weeks ago10x Clinical Expansion Advances with CLIA Lab Plans, Cleveland Clinic Partnership
10x Genomics says it is on track to build out a CLIA-certified laboratory set to open next year, part of the spatial and single-cell tools developer’s...
-
Uncategorized2 weeks ago
Blood Cancer Therapies Informed by Spatial Remodeling of Bone Marrow
Blood Cancer Therapies Informed by Spatial Remodeling of Bone Marrow
-
Uncategorized2 weeks agoAgios scraps sickle cell drug
The study failure costs Agios a chance to one-up Novo Nordisk and represents yet another setback in a disease that’s frustrated drugmakers of late.
-
Uncategorized2 weeks agoOpinion: Pete Hegseth, ‘The Odyssey,’ and the testosterone myth
The past week has brought us two similar ideas of masculinity, separated by 4,000 years. When Defense Secretary Pete Hegseth announced the initiation of testosterone screening...
-
Uncategorized2 weeks ago
Agios axes next-gen sickle cell candidate after it fails to best Novo’s asset
Agios Pharmaceuticals’ sickle cell disease candidate didn’t prove any better than Novo Nordisk’s investigational PK activator or the biopharma’s own asset that is currently under FDA...
-
Uncategorized2 weeks agoeBook: The latest developments in vaccines and virology
The 2025 Global Vaccines Market Report from the World Health Organization (WHO) reports a total financial value of $66 billion in 2024, though this is predicted...
-
Uncategorized2 weeks agoSTAT+: Advocates say federal funding is being cut from groups fighting HIV
WASHINGTON — Community-based groups that provide HIV testing and prevention tools are pushing federal health officials to renew a crucial funding program that recently lapsed. If...
-
Uncategorized2 weeks agoSTAT+: Pharmalittle: We’re reading about Novo suing Lilly over ‘deceptive’ ads, a fugitive’s secret life in biotech, and more
Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are hovering over the Pharmalot campus again, but our spirits remain sunny,...
